Constantine Gennatas

Summary

Affiliation: University of Athens
Country: Greece

Publications

  1. ncbi Synchronous gastric adenocarcinoma and gastrointestinal stromal tumor (GIST) of the stomach: a case report
    Theodosios Theodosopoulos
    2nd Department of Surgery, University Hospital Aretaieion, Athens, Greece
    World J Surg Oncol 9:60. 2011
  2. ncbi Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas
    Constantine Gennatas
    Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
    In Vivo 20:301-5. 2006
  3. ncbi Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO)
    Constantine Gennatas
    Department of Surgery, Areteion Hospital, University of Athens, Greece
    Tumori 92:13-7. 2006
  4. ncbi Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer
    Constantine Gennatas
    Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
    Anticancer Res 26:549-52. 2006
  5. ncbi A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    C Gennatas
    Medical Oncology Clinic Department of Surgery, Areteion Hospital, University of Athens, Greece
    J Chemother 18:538-44. 2006
  6. ncbi Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer
    C Gennatas
    Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
    Anticancer Res 28:1923-6. 2008
  7. ncbi The role of capecitabine in the management of tumors of the digestive system
    Constantine Gennatas
    Areteion Hospital, Oncology Clinic, Department of Surgery, Athens, Greece
    Rev Recent Clin Trials 4:1-11. 2009
  8. ncbi Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results
    Vasiliki Michalaki
    Oncology Clinic, University of Athens, School of Medicine, Aretaieion Hospital, Athens, Greece
    Anticancer Res 30:3051-4. 2010
  9. ncbi Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma
    Constantine Gennatas
    Second Department of Surgery, Areteion Hospital, University of Athens, Greece
    Tumori 88:32-6. 2002
  10. ncbi Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor
    Constantine Gennatas
    Oncology Clinic, Second Department of Surgery, Aretaieion Hospital, Athens Medical School, Athens, Greece
    World J Surg Oncol 10:181. 2012

Collaborators

Detail Information

Publications13

  1. ncbi Synchronous gastric adenocarcinoma and gastrointestinal stromal tumor (GIST) of the stomach: a case report
    Theodosios Theodosopoulos
    2nd Department of Surgery, University Hospital Aretaieion, Athens, Greece
    World J Surg Oncol 9:60. 2011
    ..Various hypotheses have been proposed in order to explain this rare simultaneous development, but even though it's cause has not been proven yet...
  2. ncbi Gemcitabine combined with 5-fluorouracil for the treatment of advanced carcinoma of the pancreas
    Constantine Gennatas
    Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
    In Vivo 20:301-5. 2006
    ..The aim of the study was to evaluate the safety and efficacy of the combination of gemcitabine and 5-FU in patients with advanced adenocarcinoma of the pancreas...
  3. ncbi Third-line hormonal treatment with exemestane in postmenopausal patients with advanced breast cancer progressing on letrozole or anastrozole. A phase II trial conducted by the Hellenic Group of Oncology (HELGO)
    Constantine Gennatas
    Department of Surgery, Areteion Hospital, University of Athens, Greece
    Tumori 92:13-7. 2006
    ..The purpose of the study was to assess the antitumor efficacy and tolerance of exemestane administered as third-line hormonal therapy to postmenopausal women with metastatic breast cancer refractory to letrozole and anastrozole...
  4. ncbi Gemcitabine in combination with vinorelbine for heavily pretreated advanced breast cancer
    Constantine Gennatas
    Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
    Anticancer Res 26:549-52. 2006
    ..To evaluate the activity and toxicity of gemcitabine and vinorelbine in patients with metastatic breast cancer (MBC), previously treated with anthracyclines alone or with taxanes...
  5. ncbi A prospective randomized study of irinotecan (CPT-11), leucovorin (LV) and 5-fluorouracil (5FU) versus leucovorin and 5-fluorouracil in patients with advanced colorectal carcinoma
    C Gennatas
    Medical Oncology Clinic Department of Surgery, Areteion Hospital, University of Athens, Greece
    J Chemother 18:538-44. 2006
    ..35% in group B; p=0.032) and mucositis (2% vs. 14%; p=0.017). The regimen containing irinotecan showed activity in advanced colorectal cancer. The overall safety data confirm this combination as a well-tolerated treatment...
  6. ncbi Irinotecan plus capecitabine as first-line chemotherapy in advanced colorectal cancer
    C Gennatas
    Oncology Clinic, Department of Surgery, Areteion Hospital, University of Athens, Greece
    Anticancer Res 28:1923-6. 2008
    ..v. 5-FU/leucovorin in colorectal cancer treatment. THE AIM of this study was to evaluate efficacy and safety of the combination chemotherapy of irinotecan plus capecitabine (XELIRI), in patients with advanced colorectal adenocarcinoma...
  7. ncbi The role of capecitabine in the management of tumors of the digestive system
    Constantine Gennatas
    Areteion Hospital, Oncology Clinic, Department of Surgery, Athens, Greece
    Rev Recent Clin Trials 4:1-11. 2009
    ..Relevant English-language literature was identified through searches of NCI, PubMed, ASCO.org and ESMO, ECCO meetings proceedings...
  8. ncbi Trastuzumab plus capecitabine and docetaxel as first-line therapy for HER2-positive metastatic breast cancer: phase II results
    Vasiliki Michalaki
    Oncology Clinic, University of Athens, School of Medicine, Aretaieion Hospital, Athens, Greece
    Anticancer Res 30:3051-4. 2010
    ..We evaluated the efficacy and tolerability of trastuzumab plus capecitabine and docetaxel regimen as first-line therapy...
  9. ncbi Adjuvant systemic therapy protocol for Dukes' B2 and C resectable colon carcinoma
    Constantine Gennatas
    Second Department of Surgery, Areteion Hospital, University of Athens, Greece
    Tumori 88:32-6. 2002
    ..The aim of this study was to compare the combination of 5-FU and leucovorin with the combination of 5-FU and alfa-2b interferon (IFN) in patients who had undergone "curative" resection foronocarcinoma...
  10. ncbi Successful treatment with the mTOR inhibitor everolimus in a patient with perivascular epithelioid cell tumor
    Constantine Gennatas
    Oncology Clinic, Second Department of Surgery, Aretaieion Hospital, Athens Medical School, Athens, Greece
    World J Surg Oncol 10:181. 2012
    ..On this basis, we report a case of metastatic retroperitoneal PEComa treated with an oral mTOR inhibitor, with everolimus achieving significant clinical response...
  11. ncbi Abscess formation mimicking disease progression, in a patient with metastatic renal cell carcinoma during sunitinib treatment
    Vasiliki Michalaki
    Oncology Clinic, Second Department of Surgery, University of Athens, Aretaieion Hospital, 78, V Sofias av, 115 28, Athens, Greece
    World J Surg Oncol 8:45. 2010
    ..The molecular targets of sunitinib are receptor tyrosine kinases (RTKs). Moreover, sunitinib has an additional anti-angiogenic effect through its inhibition of the vascular endothelial growth factor receptor activation...
  12. ncbi Chromophobe renal cell carcinoma with prolonged response to targeted therapy: a case report
    Vasiliki Michalaki
    Oncology Clinic, Second Department of Surgery, Areteion Hospital, University of Athens, 76 V, Sofias av, 115 28, Athens, Greece
    J Med Case Rep 6:115. 2012
    ..abstract:..
  13. ncbi Adrenocortical oncocytic carcinoma with recurrent metastases: a case report and review of the literature
    Pinelopi Argyriou
    Department of Pathology, Evangelismos General Hospital, Ipsilantou Str, Athens, Greece
    World J Surg Oncol 6:134. 2008
    ..Adrenal cortex oncocytic carcinoma (AOC) represents an exceptional pathological entity, since only 22 cases have been documented in the literature so far...